MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD | Market Cap | 10.49M +266.8% |
| Revenue (ttm) | n/a |
| Net Income | -5.49M |
| EPS | -0.01 |
| Shares Out | 7.28M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 33,448 |
| Average Volume | 13,377 |
| Open | 1.460 |
| Previous Close | 1.440 |
| Day's Range | 1.180 - 1.460 |
| 52-Week Range | 0.500 - 6.000 |
| Beta | -1.51 |
| RSI | 69.69 |
| Earnings Date | May 13, 2026 |
About MindBio Therapeutics
MindBio Therapeutics Corp., together with its subsidiaries, engages in researching, developing, and testing psychedelic substances as a potential treatment for the management of various mental health conditions in Australasia. Its lead drug candidate is MB22001, a form of lysergic acid diethylamide in Phase 2A trials. The company also develops wearable devices to collect biometric data in mental health patients taking psychedelic medicines; and invests in research that forms the basis for developing novel and clinically proven treatments for de... [Read more]
News
MindBio Files Patent Applications in 15 World Firsts
15 world first discoveries transform our understanding of physiological reactions to neurologically active substances that when consumed, affect the central nervous system and speech. The prediction m...
MindBio Appoints Market Maker Venture Liquidity Providers
MindBio has appointed Venture Liquidity Providers Inc to initiate its market making service to provide assistance in maintaining an orderly trading market
MindBio Deploys New Technology Intox Collect™; Expands CNS Drug Detection Capabilities with Voice & Facial Recognition
New technology Intox Collect™ has been completed for collection and analysis of voice and facial recognition data using AI for alcohol and a range of new substances that effect the central nervous sys...
MindBio Announces Closing of Private Placement
Vancouver, British Columbia – April 1, 2026 – TheNewswire - MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF) (the “ Company ” or “ MindBio ”), a biotechnology company that is ...
MindBio Announces Upsize to Private Placement up to $1.5 Million
Vancouver, British Columbia – TheNewswire - March 19, 2026 – MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company comm...
MindBio Appoints National Drug Policy & Mining Industry Expert to Lead South American Mining Industry Commercialisation
Vancouver, British Columbia – TheNewswire - February 24, 2026 – MindBio Therapeutics Corp. (CSE: MBIO | Frankfurt: WF6 | OTCQB: MBQIF) (“MindBio” or the “Company”), a biotechnology innovator commercia...
MindBio Announces Private Placement to Raise up to $650,000
Vancouver, British Columbia - TheNewswire - February 18, 2026 – MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6); (OTCQB:MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company t...
MindBio Advances Large-Scale Deployment of Voice Intoxication Detection Through Integrated Edge AI Hardware-Software Platform
Vancouver, British Columbia – TheNewswire - February 18, 2026 – MindBio Therapeutics Corp. (CSE: MBIO) (Frankfurt: WF6) (OTCQB: MBQIF) (“MindBio” or the “Company”) , a biotechnology company commercial...
MindBio Deploys Engineers to South American Mining Industry, Accelerates Investment in Enterprise Voice AI Health Diagnostics.
Vancouver, British Columbia – TheNewswire - February 4, 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), is pleased to report following it...
MindBio to Revolutionise Drug and Alcohol Testing in the Mining Industry using AI Voice-Based Drug & Alcohol Detection Solution
CEO Meets with Mining and Health Executives in South America to discuss deployment of new drug and alcohol screening solution. Mining deployment of the technology would disrupt drug and alcohol testi...
MindBio Targets Global Digital Health Diagnostics Market with World First AI Powered Speech Analytics Technology
Vancouver, British Columbia – TheNewswire - January 27, 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company that cond...
MindBio Showcases World First Voice AI Intoxication Detection Technology in USA. Targets Health Diagnostics Market with Exciting New Technology
Vancouver, British Columbia – TheNewswire - January 2 1 , 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company that co...
MindBio Lists for Trading on OTCQB Market
Vancouver, British Columbia – TheNewswire - January 21, 202 6 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company that con...